Coding Companion
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Letters to the Editor
letters to the Editor Porphyria, Cardiopulmonary Bypass, and heart with additional hemorrhage into the pericardial sac (5). Peri- cardiocentesis, however, can be a temporizing measure in the se- Volatile Anesthetics verely compromised patient (4,7,8) until definitive surgical estab- lishment of a pericardial window. A pericardial window can be To the Editor: established under local anesthesia (9) via the subxiphoid or lateral We take issue with Stevens et al’s contentious statements in their thoracotomy approach (1,2,5,8,9). The subxiphoid approach is less discussion of volatile anesthetics in the patient with acute intermit- useful for trauma because limited surgical exposure may preclude tent porphyria undergoing mitral valve replacement (1). repair of cardiac wounds (2). However, a pericardial window dur- In the “pre-propofol” era, the safe and appropriate use of halo- ing awake lateral thoracotomy may be both poorly tolerated and thane and isoflurane in porphyric patients was established (2). dangerous in the distressed, moving patient (7). Recent reports of the successful use of isoflurane in porphyric A blunt trauma victim (2) recently presented for an emergent patients undergoing cardiac surgery also exist (3,4). As the authors surgical pericardial window for recurrent acute pericardial tampon- themselves allude to a report of elevated porphyrins after propofol ade. Although the patient was not hypotensive, jugular venous anesthesia in acute intermittent porphyria, favoring propofol over distention, pulsus paradoxus (1,3,7), patient distress (4), and echo- inhaled anesthetics because of the latter’s implied lack of a “safety cardiographic signs were present. As an alternative to endotracheal record” cannot be supported. -
Preoperative Skin Antisepsis with Chlorhexidine Gluconate Versus Povidone-Iodine: a Prospective Analysis of 6959 Consecutive Spinal Surgery Patients
CLINICAL ARTICLE J Neurosurg Spine 28:209–214, 2018 Preoperative skin antisepsis with chlorhexidine gluconate versus povidone-iodine: a prospective analysis of 6959 consecutive spinal surgery patients George M. Ghobrial, MD, Michael Y. Wang, MD, Barth A. Green, MD, Howard B. Levene, MD, PhD, Glen Manzano, MD, Steven Vanni, DO, DC, Robert M. Starke, MD, MSc, George Jimsheleishvili, MD, Kenneth M. Crandall, MD, Marina Dididze, MD, PhD, and Allan D. Levi, MD, PhD Department of Neurological Surgery and The Miami Project to Cure Paralysis, University of Miami Miller School of Medicine, Miami, Florida OBJECTIVE The aim of this study was to determine the efficacy of 2 common preoperative surgical skin antiseptic agents, ChloraPrep and Betadine, in the reduction of postoperative surgical site infection (SSI) in spinal surgery proce- dures. METHODS Two preoperative surgical skin antiseptic agents—ChloraPrep (2% chlorhexidine gluconate and 70% iso- propyl alcohol) and Betadine (7.5% povidone-iodine solution)—were prospectively compared across 2 consecutive time periods for all consecutive adult neurosurgical spine patients. The primary end point was the incidence of SSI. RESULTS A total of 6959 consecutive spinal surgery patients were identified from July 1, 2011, through August 31, 2015, with 4495 (64.6%) and 2464 (35.4%) patients treated at facilities 1 and 2, respectively. Sixty-nine (0.992%) SSIs were observed. There was no significant difference in the incidence of infection between patients prepared with Beta- dine (33 [1.036%] of 3185) and those prepared with ChloraPrep (36 [0.954%] of 3774; p = 0.728). Neither was there a significant difference in the incidence of infection in the patients treated at facility 1 (52 [1.157%] of 4495) versus facility 2 (17 [0.690%] of 2464; p = 0.06). -
ICD-9 Diagnosis Codes Effective 10/1/2011 (V29.0) Source: Centers for Medicare and Medicaid Services
ICD-9 Diagnosis Codes effective 10/1/2011 (v29.0) Source: Centers for Medicare and Medicaid Services 0010 Cholera d/t vib cholerae 00801 Int inf e coli entrpath 01086 Prim prg TB NEC-oth test 0011 Cholera d/t vib el tor 00802 Int inf e coli entrtoxgn 01090 Primary TB NOS-unspec 0019 Cholera NOS 00803 Int inf e coli entrnvsv 01091 Primary TB NOS-no exam 0020 Typhoid fever 00804 Int inf e coli entrhmrg 01092 Primary TB NOS-exam unkn 0021 Paratyphoid fever a 00809 Int inf e coli spcf NEC 01093 Primary TB NOS-micro dx 0022 Paratyphoid fever b 0081 Arizona enteritis 01094 Primary TB NOS-cult dx 0023 Paratyphoid fever c 0082 Aerobacter enteritis 01095 Primary TB NOS-histo dx 0029 Paratyphoid fever NOS 0083 Proteus enteritis 01096 Primary TB NOS-oth test 0030 Salmonella enteritis 00841 Staphylococc enteritis 01100 TB lung infiltr-unspec 0031 Salmonella septicemia 00842 Pseudomonas enteritis 01101 TB lung infiltr-no exam 00320 Local salmonella inf NOS 00843 Int infec campylobacter 01102 TB lung infiltr-exm unkn 00321 Salmonella meningitis 00844 Int inf yrsnia entrcltca 01103 TB lung infiltr-micro dx 00322 Salmonella pneumonia 00845 Int inf clstrdium dfcile 01104 TB lung infiltr-cult dx 00323 Salmonella arthritis 00846 Intes infec oth anerobes 01105 TB lung infiltr-histo dx 00324 Salmonella osteomyelitis 00847 Int inf oth grm neg bctr 01106 TB lung infiltr-oth test 00329 Local salmonella inf NEC 00849 Bacterial enteritis NEC 01110 TB lung nodular-unspec 0038 Salmonella infection NEC 0085 Bacterial enteritis NOS 01111 TB lung nodular-no exam 0039 -
Incision & Drainage Informed Consent
Jeri Shuster, M.D., P.A. and Women’s Center, Inc. JERI SHUSTER, M.D., PA & WOMEN’SJeri Shuster, CENTER, INC M.D.,. P.A. Jeri Shuster, M.D., Fellowand of the Women’s American CollegeCenter, Obstetricians Inc. and Gynecologists Kathryn Cervi, C.R.N.P., Women’s Health Care Nurse Practitioner Jeri Shuster, M.D., Fellow of the American College Obstetricians and Gynecologists INFORMED CONSENT: Kathryn INCISION Cervi, C.R.N.P., AND Women’s DRAINAGE Health (I Care & D) Nurse Practitioner I hereby request and authorize Dr. to Jeri Shuster perform upon me the procedure: incision and drainage of _________________________________________________________________________ _____________________________________________________________________________________________ This procedure involves making an incision, either with a scalpel or with an electrical device, in order to enable fluid to drain from an area of the body. The procedure is intended to drain a cyst(s), abscess(es), or infected tissue. Risks include: bleeding, infection, burn injury, pain, scarring, failure to diagnose or cure the underlying condition, persistence or recurrence of the condition. To reduce risk of infection, after the procedure keep area as clean and dry as possible. Wash three times each day with lukewarm water and mild soap. Dry by gently dabbing with a soft wel to or carefully use a blow dryer on the cool setting. Follow each wash/dry with antibacterial ointment (such as Neosporin or Bacitracin). If genital incision and drainage ou is performed, y may also place antibiotic ointment onto cotton balls (not cosmetic puffs) to cover the wounds during urination or bowel movements. Benefits may include achieving a diagnosis (by distinguishing between a cyst and an abscss) and alleviating symptoms such as pain. -
Clinical Practice Guideline for the Management of Anorectal Abscess, Fistula-In-Ano, and Rectovaginal Fistula Jon D
PRACTICE GUIDELINES Clinical Practice Guideline for the Management of Anorectal Abscess, Fistula-in-Ano, and Rectovaginal Fistula Jon D. Vogel, M.D. • Eric K. Johnson, M.D. • Arden M. Morris, M.D. • Ian M. Paquette, M.D. Theodore J. Saclarides, M.D. • Daniel L. Feingold, M.D. • Scott R. Steele, M.D. Prepared on behalf of The Clinical Practice Guidelines Committee of the American Society of Colon and Rectal Surgeons he American Society of Colon and Rectal Sur- and submucosal locations.7–11 Anorectal abscess occurs geons is dedicated to ensuring high-quality pa- more often in males than females, and may occur at any Ttient care by advancing the science, prevention, age, with peak incidence among 20 to 40 year olds.4,8–12 and management of disorders and diseases of the co- In general, the abscess is treated with prompt incision lon, rectum, and anus. The Clinical Practice Guide- and drainage.4,6,10,13 lines Committee is charged with leading international Fistula-in-ano is a tract that connects the perine- efforts in defining quality care for conditions related al skin to the anal canal. In patients with an anorec- to the colon, rectum, and anus by developing clinical tal abscess, 30% to 70% present with a concomitant practice guidelines based on the best available evidence. fistula-in-ano, and, in those who do not, one-third will These guidelines are inclusive, not prescriptive, and are be diagnosed with a fistula in the months to years after intended for the use of all practitioners, health care abscess drainage.2,5,8–10,13–16 Although a perianal abscess workers, and patients who desire information about the is defined by the anatomic space in which it forms, a management of the conditions addressed by the topics fistula-in-ano is classified in terms of its relationship to covered in these guidelines. -
A Rare Case of Perforated Descending Colon Cancer Complicated with a Fistula and Abscess of Left Iliopsoas and Ipsilateral Obturator Muscle
Hindawi Publishing Corporation Case Reports in Surgery Volume 2014, Article ID 128506, 5 pages http://dx.doi.org/10.1155/2014/128506 Case Report A Rare Case of Perforated Descending Colon Cancer Complicated with a Fistula and Abscess of Left Iliopsoas and Ipsilateral Obturator Muscle Alban Cacurri,1 Gaspare Cannata,1 Stefano Trastulli,2 Jacopo Desiderio,2 Antongiulio Mangia,1 Olga Adamenko,2 Eleonora Pressi,2 Giorgio Giovannelli,2 Giuseppe Noya,1 and Amilcare Parisi2 1 Department of General and Oncologic Surgery, University of Perugia, 06157 Perugia, Italy 2 Department of Digestive and Liver Surgery Unit, St. Maria Hospital, 05100 Terni, Italy Correspondence should be addressed to Gaspare Cannata; [email protected] Received 20 November 2013; Accepted 9 February 2014; Published 16 March 2014 Academic Editors: F. Catena and A. Cho Copyright © 2014 Alban Cacurri et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Perforation of descending colon cancer combined with iliopsoasabscessandfistulaformationisarareconditionandhasbeen reported few times. A 67-year-old man came to our first aid for an acute pain in the left iliac fossa, in the flank, and in the ipsilateral thigh. Ultrasonography and computed tomography revealed a left abdominal wall, retroperitoneal, and iliopsoas abscess that also involved the ipsilateral obturator muscle. It proceeded with an exploratory laparotomy that showed a tumor of the descending colon adhered and perforated in the retroperitoneum with abscess of the iliopsoas muscle on the left-hand side, with presence of a fistula and liver metastases. -
Original Article Efficacy of Radical Incision and Drainage for Perianal Abscesses and Related Serum Activin a Levels
Int J Clin Exp Med 2020;13(7):5100-5107 www.ijcem.com /ISSN:1940-5901/IJCEM0111399 Original Article Efficacy of radical incision and drainage for perianal abscesses and related serum activin A levels Hengqing Gao1, Runping Liu1, Zhengchun Yang3, Xiaoqiang Wang1, Wei Wang1, Furao Gong1, Jing Hu2 Departments of 1Anorectal, 2Science and Education, Zigong Hospital of Traditional Chinese Medicine, Zigong, Sichuan Province, China; 3Sichuan Administration of Traditional Chinese Medicine, Chengdu, Sichuan Province, China Received March 25, 2020; Accepted April 24, 2020; Epub July 15, 2020; Published July 30, 2020 Abstract: Objective: To explore the efficacy of radical incision and drainage for patients with perianal abscess and its effect on serum activin A (ACTA) levels. Methods: A total of 128 patients with perianal abscesses were randomly divided into group A (radical incision and drainage, n = 64) and group B (simple incision and drainage, n = 64). Results: Visual analogue scale (VAS) score, gas, postoperative persistent infection and wound healing time in group A were significantly lower than those in group B (all P<0.001). Compared with group B, group A had significantly higher effective treatment rates, but lower serum ACTA levels 3 days after operation and lower recurrence rate of perianal abscess and anal fistula (P<0.001). Conclusion: The application of radical incision and drainage in patients with perianal abscesses can effectively reduce postoperative pain, and also has the advantages of faster postopera- tive recovery, lower incidence of adverse events and reduced inflammatory response. Radical incision and drainage and serum ACTA levels 3 days after operation are key factors for the recurrence of perianal abscess and anal fistula in patients with perianal abscesses. -
Clinical Characteristics and Incidence of Perianal Diseases in Patients with Ulcerative Colitis
Annals of Original Article Coloproctology Ann Coloproctol 2018;34(3):138-143 pISSN 2287-9714 eISSN 2287-9722 https://doi.org/10.3393/ac.2017.06.08 www.coloproctol.org Clinical Characteristics and Incidence of Perianal Diseases in Patients With Ulcerative Colitis Yong Sung Choi1, Do Sun Kim2, Doo Han Lee2, Jae Bum Lee2, Eun Jung Lee2, Seong Dae Lee2, Kee Ho Song2, Hyung Joong Jung2 Departments of 1Gastroenterology and 2Surgery, Daehang Hospital, Seoul, Korea Purpose: While perianal disease (PAD) is a characteristic of patients with Crohn disease, it has been overlooked in pa- tients with ulcerative colitis (UC). Thus, our study aimed to analyze the incidence and the clinical features of PAD in pa- tients with UC. Methods: We reviewed the data on 944 patients with an initial diagnosis of UC from October 2003 to October 2015. PAD was categorized as hemorrhoids, anal fissures, abscesses, and fistulae after anoscopic examination by experienced proctol- ogists. Data on patients’ demographics, incidence and types of PAD, medications, surgical therapies, and clinical course were analyzed. Results: The median follow-up period was 58 months (range, 12–142 months). Of the 944 UC patients, the cumulative in- cidence rates of PAD were 8.1% and 16.0% at 5 and 10 years, respectively. The incidence rates of bleeding hemorrhoids, anal fissures, abscesses, and fistulae at 10 years were 6.7%, 5.3%, 2.6%, and 3.4%, respectively. The cumulative incidence rates of perianal sepsis (abscess or fistula) were 2.2% and 4.5% at 5 and 10 years, respectively. In the multivariate analyses, male sex (risk ratio [RR], 4.6; 95% confidence interval [CI], 1.7–12.5) and extensive disease (RR, 4.2; 95% CI, 1.6–10.9) were significantly associated with the development of perianal sepsis. -
Centers for Disease Control and Prevention Guideline for the Prevention of Surgical Site Infection, 2017
Supplementary Online Content Berríos-Torres SI, Umscheid CA, Bratzler DW, et al; Healthcare Infection Control Practices Advisory Committee. Centers for Disease Control and Prevention guideline for the prevention of surgical site infection, 2017. JAMA Surg. Published online May 3, 2017. doi:10.1001/jamasurg.2017.0904 eAppendix 1. Centers for Disease Control and Prevention, Guideline for the Prevention of Surgical Site Infection 2017 –Background, Methods and Evidence Summaries eAppendix 2. Centers for Disease Control and Prevention Guideline for the Prevention of Surgical Site Infection, 2017: Supplemental Tables This supplementary material has been provided by the authors to give readers additional information about their work. © 2017 American Medical Association. All rights reserved. 1 Downloaded From: https://jamanetwork.com/ on 09/30/2021 eAppendix 1. Centers for Disease Control and Prevention, Guideline for the Prevention of Surgical Site Infection 2017: Background, Methods and Evidence Summaries TABLE OF CONTENTS 1. BACKGROUND ........................................................................................................................................................................................................................................................... 4 1.1. Prosthetic Joint Arthroplasty ................................................................................................................................................................................................................................ -
Perianal Abscess in a 2-Year-Old Presenting with a Febrile Seizure and Swelling of the Perineum Gregory M
Oxford Medical Case Reports, 2019;01, 26–28 doi: 10.1093/omcr/omy116 Case Report CASE REPORT Perianal abscess in a 2-year-old presenting with a febrile seizure and swelling of the perineum Gregory M. Taylor, DO* and Andrew H. Erlich, DO Emergency Medicine Physician, Beaumont Hospital, Teaching Hospital of Michigan State University, Department of Emergency Medicine, Farmington Hills, MI, USA *Correspondence address. Beaumont Hospital, Teaching Hospital of Michigan State University, Farmington Hills, MI, USA. E-mail: Gregory.Taylor@ Beaumont.org Abstract An anorectal abscess, specifically a perianal abscess, is a relatively uncommon infection in children. It is a purulent fluid collection under the soft tissue outside the anus. Some of these abscesses may spontaneously drain and heal by themselves, while others may result in sepsis and require surgical intervention. The transition to a systemic illness requiring hospital admission is considered rare. We present the case of a 2-year-old male presenting with a febrile seizure and found to be systemically ill secondary to a perianal abscess. To our knowledge, this is the first case reported in the literature of a febrile seizure secondary to a perianal abscess. INTRODUCTION Vitals on arrival to the ED were as follows: 103.1°F, blood pressure of 96/78 mmHg, respiratory rate 27 breaths/min, heart A perianal abscess occurs most often in male children <1 year rate 126 beats/min, weight 12.8 kg and 100% oxygen saturation of age; however, they can occur at any age and in either sex [1]. on room air. As soon as he was brought back to the treatment In one study, an incidence was reported of up to 4.3% [1]. -
Pelvic Primary Staphylococcal Infection Presenting As a Thigh Abscess
Hindawi Publishing Corporation Case Reports in Surgery Volume 2013, Article ID 539737, 4 pages http://dx.doi.org/10.1155/2013/539737 Case Report Pelvic Primary Staphylococcal Infection Presenting as a Thigh Abscess T. O. Abbas General Surgery Department, Hamad General Hospital, Doha 3050, Qatar Correspondence should be addressed to T. O. Abbas; [email protected] Received 20 February 2013; Accepted 18 March 2013 Academic Editors: K. Honma, G. Rallis, and M. Zafrakas Copyright © 2013 T. O. Abbas. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Intra-abdominal disease can present as an extra-abdominal abscess and can follow several routes, including the greater sciatic foramen, obturator foramen, femoral canal, pelvic outlet, and inguinal canal. Nerves and vessels can also serve as a route out of the abdomen. The psoas muscle extends from the twelfth thoracic and fifth lower lumbar vertebrae to the lesser trochanter of thefemur, which means that disease in this muscle group can migrate along the muscle, out of the abdomen, and present as a thigh abscess. We present a case of a primary pelvic staphylococcal infection presenting as a thigh abscess. The patient was a 60-year-old man who presented with left posterior thigh pain and fever. Physical examination revealed a diffusely swollen left thigh with overlying erythematous, shiny, and tense skin. X-rays revealed no significant soft tissue lesions, ultrasound was suggestive of an inflammatory process, and MRI showed inflammatory changes along the left hemipelvis and thigh involving the iliacus muscle group, left gluteal region, and obturator internus muscle. -
Pediatric Review
CLINICAL REVIEW Application Type 21-227 Submission Number S-021 Submission Code SE-5 Letter Date January 31, 2008 Stamp Date January 31, 2008 PDUFA Goal Date July 31, 2008 Reviewer Name(s) Yuliya Yasinskaya, M.D. (risk/benefit, efficacy, labeling) Julie-Ann Crewalk, M.D. (clinical trial safety) Eileen Navarro, M.D. (postmarketing safety) Review Completion Date July 10, 2008 Established Name Caspofungin acetate (Proposed) Trade Name Cancidas® Therapeutic Class Enchinocandin antifungal Applicant Merck Priority Designation P Formulation lyophilized powder for infusion Dosing Regimen 50, 70mg/m2 Indications ◦ Empiric therapy of fungal infections in febrile neutropenic patients, ◦ Treatment of candidemia and the following Candida infections: intra- abdominal abscesses, peritonitis, and pleural space infections, ◦ Treatment of esophageal candidiasis, ◦ Treatment of refractory invasive aspergillosis Intended Population Children 3 months to 17 years 1 Clinical Review Yuliya Yasinskaya, M.D., Julie-Ann Crewalk, M.D,, and Eileen Navarro, M.D. NDA 21-227, S-021 Cancidas® (caspofungin acetate) Table of Contents 1 RECOMMENDATIONS/RISK BENEFIT ASSESSMENT 6 1 RECOMMENDATIONS/RISK BENEFIT ASSESSMENT 6 1.1 Recommendation on Regulatory Action.....................................................................................................6 1.1.1 Confirmation of efficacy 6 1.1.2 Confirmation of safety 9 1.2 Risk Benefit Assessment ..........................................................................................................................10